Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
H303545-10mg | 10mg | In stock | $27.90 | |
H303545-50mg | 50mg | In stock | $104.90 | |
H303545-250mg | 250mg | In stock | $470.90 | |
H303545-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,692.90 |
Selective, cell-permeable, reversible PPARγ antagonist.
Synonyms | tryptophanyl-glutamic acid | HY-128487 | Q27144978 | WE | L-tryptophyl-L-glutamic acid | l-tryptophanyl-l-glutamic acid | AS-75750 | H-Trp-Glu-OH | (2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]pentanedioic acid | Tryptophyl-Glutamate | (S)-2-[(S |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Selective, cell-permeable, reversible PPARγ antagonist (K d = 8 μM). Inhibits activity of PPARγ agonist Rosiglitazone . Active in vivo . |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Product Application: A cell-permeable dipeptide that acts as a selective and reversible peroxisome proliferator-activated receptor antagonist |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]pentanedioic acid |
---|---|
INCHI | InChI=1S/C16H19N3O5/c17-11(7-9-8-18-12-4-2-1-3-10(9)12)15(22)19-13(16(23)24)5-6-14(20)21/h1-4,8,11,13,18H,5-7,17H2,(H,19,22)(H,20,21)(H,23,24)/t11-,13-/m0/s1 |
InChi Key | PWIQCLSQVQBOQV-AAEUAGOBSA-N |
Canonical SMILES | C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N |
Isomeric SMILES | C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)N |
PubChem CID | 7009663 |
Molecular Weight | 333.34 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2217260 | Certificate of Analysis | Dec 05, 2024 | H303545 |
B2217339 | Certificate of Analysis | Dec 05, 2024 | H303545 |
B2217340 | Certificate of Analysis | Dec 05, 2024 | H303545 |
B2217359 | Certificate of Analysis | Dec 05, 2024 | H303545 |
Solubility | insoluble in EtOH; ≥14.35 mg/mL in DMSO; ≥5.76 mg/mL in H2O with ultrasonic |
---|---|
Sensitivity | Light sensitive |
1. Meng QQ et al.. (2018) Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury.. PPAR Res, 2018 (3897478). [PMID:30034460] |
2. Meng QQ et al.. (2019) PPAR-? Activation Exerts an Anti-inflammatory Effect by Suppressing the NLRP3 Inflammasome in Spinal Cord-Derived Neurons.. Mediators Inflamm, 2019 (6386729). [PMID:31015796] |
3. Hu L et al.. (2020) Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-a production.. J Radiat Res, 61 (6): (842-850). [PMID:32876675] |